Research Article
Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy
Table 1
Basic characteristics of included BLCA patients.
| | | Overall | GSE13507 | TCGA_Test | TCGA_Train | |
| | n | 569 | 165 | 200 | 204 | | | Age (mean (SD)) | 67.25 (11.10) | 65.18 (11.97) | 67.77 (11.11) | 68.42 (10.12) | 0.014 | | Gender = female/male (%) | 135/434 (23.7/76.3) | 30/135 (18.2/81.8) | 47/153 (23.5/76.5) | 58/146 (28.4/71.6) | 0.071 | | Grade (%) | | | | | <0.001 | | High grade | 440 (77.3) | 60 (36.4) | 186 (93.0) | 194 (95.1) | | | Low grade | 126 (22.1) | 105 (63.6) | 12 (6.0) | 9 (4.4) | | | Unknown | 3 (0.5) | 0 (0.0) | 2 (1.0) | 1 (0.5) | | | T (%) | | | | | <0.001 | | T1 | 83 (14.6) | 80 (48.5) | 3 (1.5) | 0 (0.0) | | | T2 | 150 (26.4) | 31 (18.8) | 56 (28.0) | 63 (30.9) | | | T3 | 210 (36.9) | 19 (11.5) | 100 (50.0) | 91 (44.6) | | | T4 | 69 (12.1) | 11 (6.7) | 23 (11.5) | 35 (17.2) | | | Ta | 24 (4.2) | 24 (14.5) | 0 (0.0) | 0 (0.0) | | | Unknown | 33 (5.8) | 0 (0.0) | 18 (9.0) | 15 (7.4) | | | M (%) | | | | | <0.001 | | M0 | 352 (61.9) | 158 (95.8) | 102 (51.0) | 92 (45.1) | | | M1 | 18 (3.2) | 7 (4.2) | 6 (3.0) | 5 (2.5) | | | MX | 197 (34.6) | 0 (0.0) | 91 (45.5) | 106 (52.0) | | | Unknown | 2 (0.4) | 0 (0.0) | 1 (0.5) | 1 (0.5) | | | N (%) | | | | | <0.001 | | N0 | 386 (67.8) | 151 (91.5) | 116 (58.0) | 119 (58.3) | | | N1 | 54 (9.5) | 8 (4.8) | 21 (10.5) | 25 (12.3) | | | N2 | 79 (13.9) | 4 (2.4) | 37 (18.5) | 38 (18.6) | | | N3 | 8 (1.4) | 1 (0.6) | 3 (1.5) | 4 (2.0) | | | NX | 37 (6.5) | 1 (0.6) | 21 (10.5) | 15 (7.4) | | | Unknown | 5 (0.9) | 0 (0.0) | 2 (1.0) | 3 (1.5) | | | Status = alive/dead (%) | 324/245 (56.9/43.1) | 96/69 (58.2/41.8) | 112/88 (56.0/44.0) | 116/88 (56.9/43.1) | 0.916 | | Risk score (median (IQR)) | 0.96 [0.66, 1.46] | 0.97 [0.65, 1.47] | 0.95 [0.66, 1.45] | 0.96 [0.66, 1.45] | 0.85 | | Risk = high/low (%) | 286/283 (50.3/49.7) | 85/80 (51.5/48.5) | 99/101 (49.5/50.5) | 102/102 (50.0/50.0) | 0.925 |
|
|
